G9a, H3K9 histone methyltransferase, combined with enhancer of zeste homolog 2 (EZH2) and transcription factor myocyte-specific enhancer factor 2C (MEF2C), inhibits the transcription of antihypertrophic genes, thereby promoting cardiac hypertrophy (47). This evidence concerns the gene EZH2 and cardiac hypertrophy.